Protalix BioTherapeutics, Inc.

Healthcare

AMEX:PLX · New York Stock Exchange American

Market Cap $165.98M Beta 0.01 P/E (TTM) 11.0

$2.22 +4.21%

+$0.09 today

52W Low $1.32High $3.19

Vol 1.82M · Avg 0.81M

EPS (TTM) $0.19Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+58.57%

Period High

$3.15

Period Low

$1.35

Latest

$2.22

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

SELLAS Life Sciences Group, Inc.

NASDAQ:SLS

$1.18B

Genfit S.A.

GNFT

$445.68M

OmniAb, Inc.

NASDAQ:OABI

$259.02M

Codexis, Inc.

NASDAQ:CDXS

$226.79M

Coherus Oncology, Inc.

NASDAQ:CHRS

$173.21M

Protara Therapeutics, Inc.

NASDAQ:TARA

$154.96M

MediWound Ltd.

NASDAQ:MDWD

$153.38M

Invivyd, Inc.

NASDAQ:IVVD

$128.55M

Neonc Technologies Holdings, Inc.

NASDAQ:NTHI

$98.78M

Sangamo Therapeutics, Inc.

NASDAQ:SGMO

$72.83M

What is the latest PLX filing?

The latest filing shown is 8-K dated May 21, 2026.

How many recent filings does PLX have?

Intrinsic Alpha currently shows 20 recent filings for PLX.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.